Medications for Beta Thalassemia
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Beta Thalassemia.
Found 1 Approved Drug for Beta Thalassemia
Reblozyl
Generic Name
Luspatercept
Reblozyl
Generic Name
Luspatercept
Form: Injection
Method of administration: Subcutaneous
FDA approval date: November 08, 2019
Classification: Erythroid Maturation Agent
REBLOZYL is an erythroid maturation agent indicated for the treatment of: Anemia in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances